Wuli Yang

16.3k total citations · 2 hit papers
227 papers, 14.3k citations indexed

About

Wuli Yang is a scholar working on Materials Chemistry, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Wuli Yang has authored 227 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Materials Chemistry, 85 papers in Biomedical Engineering and 74 papers in Biomaterials. Recurrent topics in Wuli Yang's work include Nanoplatforms for cancer theranostics (60 papers), Nanoparticle-Based Drug Delivery (58 papers) and Mesoporous Materials and Catalysis (30 papers). Wuli Yang is often cited by papers focused on Nanoplatforms for cancer theranostics (60 papers), Nanoparticle-Based Drug Delivery (58 papers) and Mesoporous Materials and Catalysis (30 papers). Wuli Yang collaborates with scholars based in China, United States and South Korea. Wuli Yang's co-authors include Changchun Wang, Jia Guo, Shoukuan Fu, Ye Tian, Jianhua Hu, Baisong Chang, Zhiqing Pang, Ranran Guo, Qin Jiang and Shun Shen and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Wuli Yang

218 papers receiving 14.1k citations

Hit Papers

Platelet Membrane‐Camoufl... 2018 2026 2020 2023 2020 2018 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wuli Yang 6.1k 5.7k 5.1k 3.0k 1.6k 227 14.3k
Igor I. Slowing 4.5k 0.7× 7.1k 1.2× 5.0k 1.0× 2.7k 0.9× 1.5k 0.9× 105 13.9k
Brian G. Trewyn 4.0k 0.7× 6.9k 1.2× 4.9k 1.0× 2.8k 1.0× 1.5k 0.9× 85 12.9k
Joseph J. Richardson 5.5k 0.9× 5.1k 0.9× 4.3k 0.9× 2.1k 0.7× 1.9k 1.1× 167 15.3k
Fangqiong Tang 4.3k 0.7× 6.8k 1.2× 3.8k 0.7× 2.8k 0.9× 1.0k 0.6× 164 12.8k
Qianjun He 9.3k 1.5× 7.7k 1.3× 5.6k 1.1× 3.5k 1.2× 848 0.5× 203 16.9k
Kang Liang 4.9k 0.8× 6.4k 1.1× 2.7k 0.5× 2.7k 0.9× 1.3k 0.8× 278 15.6k
Yanlan Liu 6.2k 1.0× 4.9k 0.9× 2.9k 0.6× 2.7k 0.9× 935 0.6× 108 13.1k
Yunlu Dai 10.3k 1.7× 8.7k 1.5× 4.1k 0.8× 3.0k 1.0× 856 0.5× 208 16.8k
Jiwei Cui 4.5k 0.7× 3.4k 0.6× 4.3k 0.8× 2.2k 0.8× 1.5k 0.9× 244 12.2k
Hangrong Chen 10.4k 1.7× 11.4k 2.0× 5.9k 1.2× 2.7k 0.9× 1.4k 0.9× 311 20.5k

Countries citing papers authored by Wuli Yang

Since Specialization
Citations

This map shows the geographic impact of Wuli Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuli Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuli Yang more than expected).

Fields of papers citing papers by Wuli Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wuli Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuli Yang. The network helps show where Wuli Yang may publish in the future.

Co-authorship network of co-authors of Wuli Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Wuli Yang. A scholar is included among the top collaborators of Wuli Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wuli Yang. Wuli Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xuejing, et al.. (2025). High intensity forced ultrasound-driven ferroptosis as a strategy for anti-tumor immune priming. Acta Pharmaceutica Sinica B. 15(7). 3788–3804. 3 indexed citations
2.
Su, Xiaomin, Yue Liu, Jiayi Wu, et al.. (2025). An omics-based drug-HIFU combination therapy discovery for ferroptosis treatment of TNBC. Biomaterials. 324. 123535–123535.
3.
Li, Zhiguo, et al.. (2025). Progress of Palladium Nanomaterials for Tumor Diagnosis and Therapy. ACS Omega. 11(1). 180–196.
4.
Lin, Burn J., Xiaoyu Dong, Wuli Yang, et al.. (2025). The Gd3+ doping induced improvement of broadband NIR emission of NaScGe2O6:Cr3+ nanophosphors for contrast imaging lighting. Journal of Solid State Chemistry. 352. 125598–125598.
5.
Tu, Sicong, et al.. (2024). Microfluidic-based preparation of PLGA microspheres facilitating peptide sustained-release. Materials Letters. 368. 136675–136675. 7 indexed citations
6.
Zhang, Minghua, Xianxian Yao, Jianbin Xu, et al.. (2024). Biodegradable zwitterionic polymer-cloaked defective metal–organic frameworks for ferroptosis-inducing cancer therapy. International Journal of Pharmaceutics. 655. 124032–124032. 5 indexed citations
7.
Ouyang, Boshu, Caihua Shan, Shun-Qing Shen, et al.. (2024). AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer. Nature Communications. 15(1). 7560–7560. 20 indexed citations
8.
Yu, Xiangrong, Xuejing Li, Qingwang Chen, et al.. (2024). High Intensity Focused Ultrasound‐Driven Nanomotor for Effective Ferroptosis‐Immunotherapy of TNBC. Advanced Science. 11(15). e2305546–e2305546. 39 indexed citations
9.
Liu, Qingsong, Xianxian Yao, Lulu Zhou, et al.. (2024). A General Molecular Structural Design for Highly Efficient Photopyroptosis that can be Activated within 10 s Irradiation. Advanced Materials. 36(29). e2401145–e2401145. 10 indexed citations
11.
Zhang, Peng, Ranran Guo, Haiting Zhang, Wuli Yang, & Ye Tian. (2023). Fluoropolymer Coated DNA Nanoclews for Volumetric Visualization of Oligonucleotides Delivery and Near Infrared Light Activated Anti‐Angiogenic Oncotherapy. Advanced Science. 10(32). e2304633–e2304633. 14 indexed citations
12.
Yao, Xianxian, et al.. (2023). Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles. Biomaterials. 303. 122395–122395. 28 indexed citations
13.
Shu, Dan, et al.. (2023). Preparation of cross-linked poly (methyl methacrylate) microspheres by post-crosslinking method and its application in light diffusers. Colloid & Polymer Science. 301(6). 613–622. 5 indexed citations
14.
Zhang, Xingyu, Jun Chen, Qin Jiang, et al.. (2020). Highly biosafe biomimetic stem cell membrane-disguised nanovehicles for cartilage regeneration. Journal of Materials Chemistry B. 8(38). 8884–8893. 36 indexed citations
15.
Peng, Haibao, et al.. (2020). Biomimetic Mesoporous Silica Nanoparticles for Enhanced Blood Circulation and Cancer Therapy. ACS Applied Bio Materials. 3(11). 7849–7857. 40 indexed citations
16.
Wang, Sheng, Song Wang, Qin Zhang, et al.. (2019). Red-blood-cell-membrane-enveloped magnetic nanoclusters as a biomimetic theranostic nanoplatform for bimodal imaging-guided cancer photothermal therapy. Journal of Materials Chemistry B. 8(4). 803–812. 49 indexed citations
17.
Deng, Chao, Qian Zhang, Cong Fu, et al.. (2019). Template-Free Synthesis of Chemically Asymmetric Silica Nanotubes for Selective Cargo Loading and Sustained Drug Release. Chemistry of Materials. 31(11). 4291–4298. 17 indexed citations
18.
Liu, Donghua, Xiaosong Chen, Yibin Hu, et al.. (2018). Raman enhancement on ultra-clean graphene quantum dots produced by quasi-equilibrium plasma-enhanced chemical vapor deposition. Nature Communications. 9(1). 193–193. 161 indexed citations
19.
Men, Yongzhi, Shaojun Peng, Peng Yang, et al.. (2018). Biodegradable Zwitterionic Nanogels with Long Circulation for Antitumor Drug Delivery. ACS Applied Materials & Interfaces. 10(28). 23509–23521. 98 indexed citations
20.
Wang, Changchun, Wuli Yang, & Shoukuan Fu. (2003). Functionalization of Colloidal Particles. 115. 110–130. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026